Handmade quality · Free shipping over $75 · Explore the atelier

AZD6244 (Selumetinib) - MEK Inhibitor. CAS# 606143-52-6 0192 Effects of ticlopidine on pharmacokinetics

SKU: 59286331650

4.5
USD29.00 USD56.00

Pay in 4 interest-free payments of $7.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP3174 in rats

Suppression of the clinical and cytokine response to endotoxin by RWJ-67657

and 2-HG production in HT1080 and U87MG cells with IC50 < 0

2S)-1-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-(3-metho xyphenyl)-2-propanyl]acetamide (AZD-5423)

2017 Feb 14

AZD6244 (Selumetinib) - MEK Inhibitor. CAS# 606143-52-6 0192 Effects of ticlopidine on pharmacokineticsAZD6244, CAS No. 606143 52 6, (Selumetinib, ARRY 142886) is an orally active, highly potent and selective non ATP competitive MEK inhibitor, inhibiting MEK1 with an IC50 of 14 nM. In vitro cell viability inhibition screening of a tumor cell line panel found that cell lines harboring BRAF or RAS mutations were more likely to be sensitive to AZD6244. Treatment of primary HCC cells with AZD6244 led to growth inhibition, caspase 3 and caspase 7

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products